First Quarter 2012 Investor Conference Webinar

on June 7, 2012

On June 7 JSC Olainfarm organized its first quarter 2012 Investor Conference Online Webinar for investors. During the webinar the member of the management board of JSC Olainfarm Salvis Lapiņš analysed the financial results of first quarter 2012 and informed about the company’s future perspectives.

As Salvis Lapiņš informed during the webinar, JSC Olainfarm currently owns 36 different pharmacy stores, but during the next year it is planned to increase the number to 50-60 pharmacies.
According to Salvis Lapiņš, it is soon planned to rebrand the acquired pharmacies uniting them under the name Latvijas aptieka.
Also, it was noted that on May 31, 2012 the registration of “Olvazol” capsules was finished in Ukraine.
Answering the questions sent in by the investors, Salvis Lapiņš informed that the retained profit of the year 2011 will be invested in company’s development – purchase of equipment and renovation of JSC Olainfarm premises in order to ensure thermal efficiency, as well as in workforce and 2 million lats (2.85 million EUR) in purchases of new pharmacy stores.

The recorded Olainfarm webinar is available online:, and the presentation, demonstrated during the webinar is available here: Webinar Presentation: 1st quarter of 2012

Olainfarm thanks all participants, who joined the webinar, and encourages everybody to follow company’s announcements to get information on the next webinar!


JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 35 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

Information prepared by:

Salvis Lapins
Member of the Board
JSC Olainfarm
Tel: +371 6 7013 717
Cell: +371 2 6448 873

First Quarter 2012 Investor Conference Webinar